Neurotrophin Signal Transduction in Medulloblastoma
Overview
Authors
Affiliations
The members of the neurotrophin family play key biological roles in the development of the nervous system. Based on studies initially in cell lines (e.g., the rat pheochromocytoma PC12 cells), neurotrophins have been found to be important mediators of proliferation, differentiation, and survival in the normal brain, but their role in brain tumors remains unclear. Since neurotrophins and neurotrophin receptors are frequently detected in biopsy samples of central nervous system medulloblastomas, efforts have been undertaken in several laboratories to elucidate the potential effects of neurotrophins on the growth and differentiation of these tumors. Results from these studies may have both basic and clinical implications because medulloblastomas resemble embryonic neuroectodermal stem cells and/or their immature neuronal and glial progeny. This review focuses on recent developments in our understanding of the role of neurotrophins in medulloblastomas, especially the ability of nerve growth factor to induce apoptosis in vitro in medulloblastomas.
Antitumor Activities and Cellular Changes Induced by TrkB Inhibition in Medulloblastoma.
Thomaz A, Pinheiro K, Souza B, Gregianin L, Brunetto A, Brunetto A Front Pharmacol. 2019; 10:698.
PMID: 31297057 PMC: 6606946. DOI: 10.3389/fphar.2019.00698.
The association of NF2 (neurofibromin 2) gene polymorphism and the risk of medulloblastomas.
Zhao C, Chen Q, Li C, Yang J, Li C, Zhou Y Neurol Sci. 2018; 39(7):1175-1183.
PMID: 29637450 DOI: 10.1007/s10072-018-3327-0.
Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.
Iyer R, Wehrmann L, Golden R, Naraparaju K, Croucher J, MacFarland S Cancer Lett. 2016; 372(2):179-86.
PMID: 26797418 PMC: 4792275. DOI: 10.1016/j.canlet.2016.01.018.
Thomaz A, Jaeger M, Buendia M, Bambini-Junior V, Gregianin L, Brunetto A J Mol Neurosci. 2015; 59(3):326-33.
PMID: 26614346 DOI: 10.1007/s12031-015-0689-0.
Kim Y, Cho S, Lee S, Choi S, Phi J, Kim S J Neurooncol. 2011; 106(1):89-98.
PMID: 21720807 DOI: 10.1007/s11060-011-0656-8.